General

Showing 2145–2160 of 2225 results

Article: Three photochemical pathogen inactivation methods impair platelet function with different underlying biochemical mechanisms
€3.03 Only for registered clients
Article: Three-year follow-up data of ELOQUENT-2: sustained benefit of elotuzumab in patients with relapsed/ refractory multiple myeloma
€3.03 Only for registered clients
Article: Thrombin generation in the plasma of sickle cell trait adults shows prothrombotic profile as compared to normal adults
€3.03 Only for registered clients
Article: Thrombo-embolic events in cancer patients with impaired renal function
€3.03 Only for registered clients
Article: ThromboGenomics implementation in Belgium
€3.03 Only for registered clients
Article: THROMBOPROPHYLAXIS AND COAGULOPATHY IN COVID-19
€3.03 Only for registered clients
Article: THROMBOSIS AND HAEMOSTASIS SIXTY YEARS AGO
€3.03 Only for registered clients
Article: Thrombosis during assisted reproduction
€3.03 Only for registered clients
Article: Thrombotic thrombocytopenic purpura in pregnancy: a case report
€3.03 Only for registered clients
Article: To BEACOPP or not to BEACOPP: That is the question
€3.03 Only for registered clients
Article: Towards a chemotherapy-free future for patients with follicular lymphoma
€3.03 Only for registered clients
Article: Towards an evidence-based approach for diagnosis and management of adnexal masses: findings of the International Ovarian Tumour Analysis (IOTA) studies
€3.03 Only for registered clients
Article: TPFE (docetaxel, cisplatin, 5-FU and cetuximab) for recurrent mucoepidermoid carcinoma of the parotid gland: an aggressive strategy for an aggressive disease
€3.03 Only for registered clients
Article: Transforming growth factor β: friend or foe in disguise?
€3.03 Only for registered clients
Article: Treatment for Chronic Lymphocytic Leukaemia
€3.03 Only for registered clients
Article: Treatment of mantle cell lymphomas: recommendations of the Belgian Hematological Society
€3.03 Only for registered clients

Article: Three photochemical pathogen inactivation methods impair platelet function with different underlying biochemical mechanisms

Article: Three-year follow-up data of ELOQUENT-2: sustained benefit of elotuzumab in patients with relapsed/ refractory multiple myeloma

Article: Thrombin generation in the plasma of sickle cell trait adults shows prothrombotic profile as compared to normal adults

Article: Thrombo-embolic events in cancer patients with impaired renal function

Article: ThromboGenomics implementation in Belgium

Article: THROMBOPROPHYLAXIS AND COAGULOPATHY IN COVID-19

Article: THROMBOSIS AND HAEMOSTASIS SIXTY YEARS AGO

Article: Thrombosis during assisted reproduction

Article: Thrombotic thrombocytopenic purpura in pregnancy: a case report

Article: To BEACOPP or not to BEACOPP: That is the question

Article: Towards a chemotherapy-free future for patients with follicular lymphoma

Article: Towards an evidence-based approach for diagnosis and management of adnexal masses: findings of the International Ovarian Tumour Analysis (IOTA) studies

Article: TPFE (docetaxel, cisplatin, 5-FU and cetuximab) for recurrent mucoepidermoid carcinoma of the parotid gland: an aggressive strategy for an aggressive disease

Article: Transforming growth factor β: friend or foe in disguise?

Article: Treatment for Chronic Lymphocytic Leukaemia

Article: Treatment of mantle cell lymphomas: recommendations of the Belgian Hematological Society